Patents by Inventor Yueming Sun

Yueming Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12582654
    Abstract: A cyano-substituted pyridine and cyano-substituted pyrimidine compound and a preparation method therefor and an application thereof, which specifically relate to a compound represented by formula (I) and an isomer, a hydrate, a solvate, a pharmaceutically acceptable salt, and a prodrug thereof, and a preparation method therefor and an application thereof in the preparation of a drug as a kinase inhibitor. The compound has good inhibitory activity against kinases such as FGFR4 and mutant FGFR4V550L.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: March 24, 2026
    Assignee: BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED
    Inventors: Qiang Zhang, Leifu Yang, Nanqiao Zheng, Shannan Yu, Yueming Sun, Zhenke Guo
  • Publication number: 20250357859
    Abstract: A circuit includes an amplifier, a capacitor, a resistor, a voltage controlled current source (VCCS), and a differentiator circuit. The amplifier has a feedback input, a reference input, and an error output. The capacitor has a first capacitor terminal coupled to the error output, and second capacitor terminal. The resistor has a first resistor terminal coupled to the second capacitor terminal, and a second resistor terminal. The VCCS has a first terminal coupled to the first capacitor terminal, a second terminal coupled to the second resistor terminal, and a VCCS input. The differentiator circuit has an input coupled to the second resistor terminal, and an output coupled to the VCCS input.
    Type: Application
    Filed: May 15, 2024
    Publication date: November 20, 2025
    Applicant: Texas Instruments Incorporated
    Inventors: Yueming SUN, Yuqing WU
  • Publication number: 20250132670
    Abstract: Current balancing techniques. In an example, a circuit includes a synchronization terminal, an error amplifier, and a clock generator. The error amplifier is configured to generate a first control voltage signal based on a reference voltage and a power converter output voltage. The clock generator is configured to produce an outgoing clock signal having an outgoing clock frequency. The circuit further includes an encoder, a frequency detector, and a decoder. The encoder is coupled to the clock generator and synchronization terminal, and configured to encode the outgoing clock signal based on the first control voltage signal to provide, at synchronization terminal, an outgoing encoded clock signal. The frequency detector is coupled to synchronization terminal and configured to derive, from an incoming encoded clock signal, an incoming clock frequency. The decoder is coupled to synchronization terminal and configured to derive, from the incoming encoded clock signal, a second control voltage signal.
    Type: Application
    Filed: October 20, 2023
    Publication date: April 24, 2025
    Inventors: Yueming Sun, Yuqing Wu
  • Patent number: 12202835
    Abstract: Disclosed are a class of compounds as inhibitors of kinases such as TRK, c-MET, AXL, MER and/or VEGFR2, compositions and use thereof. In particular, disclosed are a class of compounds (as shown in formula (1)) or isomers, solvates, hydrates, pharmaceutically acceptable salts, and prodrugs thereof having strong inhibition activities for kinases such as TRK, c-MET, AXL, MER and/or VEGFR2, and pharmaceutical compositions comprising said compounds. Also disclosed is use of the compounds or pharmaceutical compositions in the preparation of a medicament for treating autoimmune diseases or cancers.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: January 21, 2025
    Assignee: BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED
    Inventors: Qiang Zhang, Shannan Yu, Yueming Sun, Leifu Yang, Nanqiao Zheng
  • Publication number: 20240400521
    Abstract: Provided are a quinazoline compound, a composition, and an application thereof, in particular, a compound represented by formula (I), a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a composition thereof, and an application thereof in the preparation for a drug that serves as a tyrosine kinase inhibitor. The compound represented by formula (I) has good inhibitory activity against EGFR and HER2 kinases.
    Type: Application
    Filed: September 29, 2022
    Publication date: December 5, 2024
    Applicant: BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED
    Inventors: Qiang ZHANG, Leifu YANG, Yueming SUN
  • Publication number: 20240313768
    Abstract: Described embodiments include a voltage converter power circuit having a high-voltage rated first transistor with a first current terminal coupled to an input voltage terminal, and a second current terminal. A second transistor, a low-voltage rated transistor, has a second control terminal, a third current terminal coupled to the second current terminal, and a fourth current terminal coupled to a switching terminal. A third transistor, a high-voltage rated transistor, has a fifth current terminal coupled to the switching terminal, a sixth current terminal, and a third control terminal. A fourth transistor, a low-voltage rated transistor, is coupled between the sixth current terminal and a ground terminal. A bleeder circuit is coupled between the seventh and eighth current terminals and is configured to prevent a voltage across the fourth transistor from exceeding a breakdown voltage.
    Type: Application
    Filed: April 25, 2023
    Publication date: September 19, 2024
    Inventors: Sri Navaneethakrishnan Easwaran, Angelo Pereira, Yueming Sun, Kae Wong, Ahmed E Hashim, Artur Lewinski
  • Publication number: 20230125046
    Abstract: A cyano-substituted pyridine and cyano-substituted pyrimidine compound and a preparation method therefor and an application thereof, which specifically relate to a compound represented by formula (I) and an isomer, a hydrate, a solvate, a pharmaceutically acceptable salt, and a prodrug thereof, and a preparation method therefor and an application thereof in the preparation of a drug as a kinase inhibitor. The compound has good inhibitory activity against kinases such as FGFR4 and mutant FGFR4V550L.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 20, 2023
    Inventors: Qiang Zhang, Leifu Yang, Nanqiao Zheng, Shannan Yu, Yueming Sun, Zhenke Guo
  • Patent number: 11509210
    Abstract: A device includes a comparator having a first comparator input configured to receive a time signal. The device also includes a subtractor having a subtractor output coupled to a second comparator input, and a first subtractor input adapted to be coupled to a voltage converter terminal. The device also includes a current source having an output coupled to a second subtractor input, and a current source input coupled to the first subtractor input. The device also includes a capacitor coupled to the second subtractor input and to ground. The device also includes a latch having an output and first and second inputs. The latch output is coupled to a control terminal of a transistor in parallel with the capacitor, the first latch input is coupled to the comparator output, and the second latch input is configured to receive a clock signal.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: November 22, 2022
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventors: Yueming Sun, Guofeng Jin
  • Patent number: 11496050
    Abstract: A device includes a first FET coupled between first and drive terminals, and is configured to turn on/off responsive to a PWM signal having a first/second state, respectively. A second FET is coupled between the first and drive terminals and is configured to turn on responsive to the PWM signal having the first state, and turn off responsive to expiration of a particular delay after the second FET turns on. A third FET is coupled between drive and second terminals, and is configured to turn on/off responsive to the PWM signal having the second/first state, respectively. A fourth FET is coupled between the drive and second terminals, and is configured to turn on responsive to the PWM signal having the second state if a switching terminal has a first voltage, and turn off responsive to the PWM signal having the first state or the switching terminal having a second voltage.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: November 8, 2022
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventors: Xufeng Wu, Wei Zhao, Yueming Sun
  • Patent number: 11407760
    Abstract: The present invention relates to a dioxinoquinoline compound of formula (I) or a pharmaceutically acceptable salt thereof. The invention also provides a preparation method of the compound of formula (I) and a pharmaceutically acceptable salt thereof, as well as uses thereof as a drug, wherein the drug acting as a tyrosine kinase (i.e. VEGFR-2 and c-MET) inhibitor is used for treating disorders related to tyrosine kinase.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: August 9, 2022
    Assignee: BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED
    Inventors: Qiang Zhang, Shannan Yu, Zhongxiang Wang, Shouye Feng, Yueming Sun, Yansheng Liu, Hongbo Zhang, Leifu Yang, Hailong Yang, Likai Zhou, Nanqiao Zheng, Chenming Hu, Zhanqiang Xu
  • Publication number: 20220002308
    Abstract: Disclosed are a class of compounds as inhibitors of kinases such as TRK, c-MET, AXL, MER and/or VEGFR2, compositions and use thereof. In particular, disclosed are a class of compounds (as shown in formula (1)) or isomers, solvates, hydrates, pharmaceutically acceptable salts, and prodrugs thereof having strong inhibition activities for kinases such as TRK, c-MET, AXL, MER and/or VEGFR2, and pharmaceutical compositions comprising said compounds. Also disclosed is use of the compounds or pharmaceutical compositions in the preparation of a medicament for treating autoimmune diseases or cancers.
    Type: Application
    Filed: November 15, 2019
    Publication date: January 6, 2022
    Inventors: Qiang Zhang, Shannan Yu, Yueming Sun, Leifu Yang, Nanqiao Zheng
  • Publication number: 20210296986
    Abstract: A device includes a first FET coupled between first and drive terminals, and is configured to turn on/off responsive to a PWM signal having a first/second state, respectively. A second FET is coupled between the first and drive terminals and is configured to turn on responsive to the PWM signal having the first state, and turn off responsive to expiration of a particular delay after the second FET turns on. A third FET is coupled between drive and second terminals, and is configured to turn on/off responsive to the PWM signal having the second/first state, respectively. A fourth FET is coupled between the drive and second terminals, and is configured to turn on responsive to the PWM signal having the second state if a switching terminal has a first voltage, and turn off responsive to the PWM signal having the first state or the switching terminal having a second voltage.
    Type: Application
    Filed: March 17, 2021
    Publication date: September 23, 2021
    Inventors: Xufeng WU, Wei ZHAO, Yueming SUN
  • Patent number: 11081957
    Abstract: A converter circuit includes a power stage circuit configured to convert an input voltage to an output voltage provided at an output, and a control circuit configured to control the power stage circuit. The control circuit is configured to operate in one of a pulse frequency modulation (“PFM”) mode and a pulse width modulation (“PWM”) mode depending on a current supplied to the output. The control circuit includes a multi-mode timer circuit configured to provide a switching signal to set an off time for each switching cycle of the power stage circuit during the PFM mode and during the PWM mode.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: August 3, 2021
    Assignee: Texas Instruments Incorporated
    Inventors: Guofeng Jin, Yueming Sun
  • Patent number: 11011984
    Abstract: A circuit includes a power stage circuit configured to perform power conversion of an input voltage to provide an output voltage at an output. The circuit further includes a driver circuit configured to drive the power stage circuit to provide the output voltage. The circuit further includes a load transient dynamic compensator configured to detect a rate of change in the output voltage during load transient and to supply a compensating signal based on the rate of change. The circuit further includes a feedback control circuit configured to generate a series of pulses to control the driver circuit based on the output voltage and the compensating signal.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: May 18, 2021
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventor: Yueming Sun
  • Publication number: 20200399285
    Abstract: The present invention relates to a dioxinoquinoline compound of formula (I) or a pharmaceutically acceptable salt thereof. The invention also provides a preparation method of the compound of formula (I) and a pharmaceutically acceptable salt thereof, as well as uses thereof as a drug, wherein the drug acting as a tyrosine kinase (i.e. VEGFR-2 and c-MET) inhibitor is used for treating disorders related to tyrosine kinase.
    Type: Application
    Filed: January 25, 2019
    Publication date: December 24, 2020
    Inventors: Qiang Zhang, Shannan Yu, Zhongxiang Wang, Shouye Feng, Yueming Sun, Yansheng Liu, Hongbo Zhang, Leifu Yang, Hailong Yang, Likai Zhou, Nanqiao Zheng, Chenming Hu, Zhanqiang Xu
  • Publication number: 20200228009
    Abstract: A converter circuit includes a power stage circuit configured to convert an input voltage to an output voltage provided at an output, and a control circuit configured to control the power stage circuit. The control circuit is configured to operate in one of a pulse frequency modulation (“PFM”) mode and a pulse width modulation (“PWM”) mode depending on a current supplied to the output. The control circuit includes a multi-mode timer circuit configured to provide a switching signal to set an off time for each switching cycle of the power stage circuit during the PFM mode and during the PWM mode.
    Type: Application
    Filed: February 4, 2020
    Publication date: July 16, 2020
    Inventors: Guofeng Jin, Yueming Sun
  • Patent number: 10608532
    Abstract: A converter circuit includes a power stage circuit configured to convert an input voltage to an output voltage provided at an output, and a control circuit configured to control the power stage circuit. The control circuit is configured to operate in one of a pulse frequency modulation (“PFM”) mode and a pulse width modulation (“PWM”) mode depending on a current supplied to the output. The control circuit includes a multi-mode timer circuit configured to provide a switching signal to set an off time for each switching cycle of the power stage circuit during the PFM mode and during the PWM mode.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: March 31, 2020
    Assignee: Texas Instrument Incorporated
    Inventors: Guofeng Jin, Yueming Sun
  • Publication number: 20200014299
    Abstract: A circuit includes a power stage circuit configured to perform power conversion of an input voltage to provide an output voltage at an output. The circuit further includes a driver circuit configured to drive the power stage circuit to provide the output voltage. The circuit further includes a load transient dynamic compensator configured to detect a rate of change in the output voltage during load transient and to supply a compensating signal based on the rate of change. The circuit further includes a feedback control circuit configured to generate a series of pulses to control the driver circuit based on the output voltage and the compensating signal.
    Type: Application
    Filed: November 26, 2018
    Publication date: January 9, 2020
    Inventor: Yueming Sun
  • Patent number: 10243463
    Abstract: An apparatus comprises a voltage supply configured to provide an input voltage, a buck-boost converter coupled to the voltage supply and comprising an inductor, and a buck-boost controller coupled to the power supply and the buck-boost converter. The buck-boost controller comprises a mode controller coupled to the buck-boost converter and a comparator coupled to the mode controller and the buck-boost converter. The comparator is configured to compare an error signal based on an output voltage of the buck boost-converter to an output current of the inductor to produce a control signal. The mode controller is configured to control the output voltage at least in part according to the control signal.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: March 26, 2019
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventors: Yueming Sun, Yihan Yao
  • Publication number: 20180358900
    Abstract: An apparatus comprises a voltage supply configured to provide an input voltage, a buck-boost converter coupled to the voltage supply and comprising an inductor, and a buck-boost controller coupled to the power supply and the buck-boost converter. The buck-boost controller comprises a mode controller coupled to the buck-boost converter and a comparator coupled to the mode controller and the buck-boost converter. The comparator is configured to compare an error signal based on an output voltage of the buck boost-converter to an output current of the inductor to produce a control signal. The mode controller is configured to control the output voltage at least in part according to the control signal.
    Type: Application
    Filed: October 10, 2017
    Publication date: December 13, 2018
    Inventors: Yueming SUN, Yihan YAO